Direct to consumer advertising emerged in 1997 when the Food and Drug Administration (FDA), ruled that pharmaceutical companies could market their products to patients directly. Most importantly the US federal policy contributed to medical neoliberalism when the reinterpretation of US regulation governing the pharmaceutical industry’s right to advertise its products to prospective patients in addition to the managed care existed. These changes in the politics, economics, and culture of health care in the US have succeeded in re-centralizing power toward pharmaceutical companies and insurance providers and away from physicians. Due to creating new structures within which medical decision-making occurs, physicians’ authority is shared or at times
